CD81 and COVID-19: Further, except immune suppression and metabolic disturbance, the HCV core protein also increased the expression of virus membrane receptors (CD81, Claudin1, LDLR, and ACE2), which increase the potential risk of HCV reinfection or coinfection with other viruses (such as HIV and COVID‐19).